Literature DB >> 26122471

The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells.

Adityarup Chakravorty1, Bill Sugden2.   

Abstract

Epstein Barr Virus (EBV) is a human tumor virus that is causally linked to malignancies such as Burkitt׳s lymphoma, and gastric and nasopharyngeal carcinomas. Tethering of EBV genomes to cellular chromosomes is required for the synthesis and persistence of viral plasmids in tumor cells. However, it is not established how EBV genomes are tethered to cellular chromosomes. We test the hypothesis that the viral protein EBNA1 tethers EBV genomes to chromosomes specifically through its N-terminal AT-hook DNA-binding domains by using a small molecule, netropsin, that has been shown to inhibit the AT-hook DNA-binding of EBNA1 in vitro. We show that netropsin forces the loss of EBV genomes from epithelial and lymphoid cells in an AT-hook dependent manner and that EBV-positive lymphoma cells are significantly more inhibited in their growth by netropsin than are corresponding EBV-negative cells.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AT-hook; Epstein Barr Virus; Netropsin

Mesh:

Substances:

Year:  2015        PMID: 26122471      PMCID: PMC4567472          DOI: 10.1016/j.virol.2015.05.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.

Authors:  Italo Tempera; Alessandra De Leo; Andrew V Kossenkov; Matteo Cesaroni; Hui Song; Noor Dawany; Louise Showe; Fang Lu; Priyankara Wikramasinghe; Paul M Lieberman
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

Review 2.  Hitchhiking of Viral Genomes on Cellular Chromosomes.

Authors:  Tami L Coursey; Alison A McBride
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

Review 3.  Plasmid Partitioning by Human Tumor Viruses.

Authors:  Ya-Fang Chiu; Bill Sugden
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

4.  Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus oriP.

Authors:  Yang Mei; Troy E Messick; Jayaraju Dheekollu; Hee Jong Kim; Sudheer Molugu; Leonardo Josué Castro Muñoz; Vera Moiskeenkova-Bell; Kenji Murakami; Paul M Lieberman
Journal:  J Virol       Date:  2022-08-29       Impact factor: 6.549

Review 5.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

6.  Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally.

Authors:  Ya-Fang Chiu; Arthur U Sugden; Kathryn Fox; Mitchell Hayes; Bill Sugden
Journal:  J Cell Biol       Date:  2017-07-10       Impact factor: 10.539

Review 7.  Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.

Authors:  Pok Man Hau; Hong Lok Lung; Man Wu; Chi Man Tsang; Ka-Leung Wong; Nai Ki Mak; Kwok Wai Lo
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

Review 8.  EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers.

Authors:  Lijun Jiang; Chen Xie; Hong Lok Lung; Kwok Wai Lo; Ga-Lai Law; Nai-Ki Mak; Ka-Leung Wong
Journal:  Theranostics       Date:  2018-10-22       Impact factor: 11.556

9.  Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus.

Authors:  Kyoung-Dong Kim; Hideki Tanizawa; Alessandra De Leo; Olga Vladimirova; Andrew Kossenkov; Fang Lu; Louise C Showe; Ken-Ichi Noma; Paul M Lieberman
Journal:  Nat Commun       Date:  2020-02-13       Impact factor: 14.919

Review 10.  EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.

Authors:  Joanna B Wilson; Evelyne Manet; Henri Gruffat; Pierre Busson; Marc Blondel; Robin Fahraeus
Journal:  Cancers (Basel)       Date:  2018-04-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.